Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice

International Journal of Cancer

Volumn 130, Issue 4, 2012, Pages 765-774

  Naseemuddin, Mohammed ^a   Iqbal, Aneeqa ^a   Nasti, Tahseen H ^a   Ghandhi, Jennifer L ^a   Kapadia, Akash D ^a   Yusuf, Nabiha ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

7,12 dimethylbenz(a)anthracene; breast cancer; chemical carcinogenesis; toll like receptor 4

Indexed keywords

CD31 ANTIGEN; DIMETHYLBENZ[A]ANTHRACENE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; TOLL LIKE RECEPTOR 4; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR GROWTH; TUMOR VASCULARIZATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-23; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOVASCULARIZATION, PATHOLOGIC; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA;

EID: 83955164280     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26100     Document Type: Article

References (53)

1. American Cancer Society. Breast cancer facts and figures. Atlanta: American Cancer Society, Inc., 2009.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics. 2008. CA Cancer J Clin 2008; 58: 71-96.
3. Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ,. Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol Nutr Food Res 2005; 49: 462-71. (Pubitemid 40780393)
4. Rudel RA, Attfield KR, Schifano JN, Brody JG,. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer 2007; 109: 2635-66. (Pubitemid 46906452)
5. Mehta RG,. Experimental basis for the prevention of breast cancer. Eur J Cancer 2000; 36: 1275-82. (Pubitemid 30407015)
6. Akira S,. TLR signaling. Curr Top Microbiol Immunol 2006; 311: 1-16. (Pubitemid 47413193)
7. Zheng SL, Augustsson-Balter K, Chang M, Hedelin B, Li L, Adami HO, Bensen J, Li G, Johnasson JE, Turner AR, Adams TS, Meyers DA, et al. Variants of toll-like receptor 4 are associated with prostate cancer risk. Cancer Res 2004; 64: 2918-22.
8. Sun J, Wiklund F, Zheng SL, Chang B, Balter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, et al. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst 2005; 97: 525-32. (Pubitemid 40590434)
9. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420: 860-7. (Pubitemid 36019639)
10. Yusuf N, Nasti TH, Long JA, Naseemuddin M, Lucas AP, Xu H, Elmets CA,. Protective Role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis. Cancer Res 2008; 68: 615-22. (Pubitemid 351380091)
11. Dusing-Swartz S, Medina D, Butelf JS, Socher SH,. Mouse mammary tumor virus genome expression in chemical carcinogen-induced mammary tumors in low- and high-tumor-incidence mouse strains. Proc Natl Acad Sci USA 1979; 76: 5360-4. (Pubitemid 10236141)
12. Overbergh L, Giulietti A, Valckx D, Decallonne B, Bouillon R, Mathieu C,. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003; 14: 33-43.
13. He D, Wu L, Kim HK, Li H, Elmets CA, Xu H,. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol 2006; 177: 6852-8. (Pubitemid 44715050)
14. Maffei CML, Mirels LF, Sobel RA, Clemons KV, Stevens DA,. Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis. Infect Immun 2004; 72: 2338-49. (Pubitemid 38419950)
15. Zhu X, Lin Z,. Modulation of cytokines production, granzyme B and perforin in murine CIK cells by Ganoderma lucidum polysaccharides. Carbohydr Polym 2006; 63: 188-97. (Pubitemid 43144661)
16. Ishihara Y, Nishikawa T, Iijima H, Matsunaga K,. Expression of matrix metalloproteinase, tissue inhibitors of metalloproteinase and adhesion molecules in silicotic mice with lung tumor metastasis. Toxicol Lett 2003; 142: 71-5. (Pubitemid 36369216)
17. Nalbant D, Youn H, Nalbant SI, Sharma S, Cobos E, Beale EG, Du Y, Williams SC,. FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells. BMC Genomics 2005; 6: 11-32.
18. Wang YM, Zhang GY, Wang Y, Hu M, Wu H, Watson D, Hori S, Alexander IE, Harris DC, Alexander SI,. Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. J Am Soc Nephrol 2006; 17: 697-706.
19. Ruiz PA, Shkoda A, Kim SC, Sartor RB, Haller D,. IL-10 gene-deficient mice lack TGF-beta/Smad-mediated TLR2 degradation and fail to inhibit proinflammatory gene expression in intestinal epithelial cells under conditions of chronic inflammation. Ann N Y Acad Sci 2006; 1072: 389-94. (Pubitemid 44448472)
20. Vinuesa E, Sola A, Jung M, Alfaro V, Hotter G,. Lipocalin-2-induced renal regeneration depends on cytokines. Am J Physiol Renal Physiol 2008; 295: F1554-F1562.
21. Han S, Robson ND, Cao Y, Qiao T, Li CY, Kontos CD, Garcia-Blanco M, Dewhirst MW,. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival. FASEB J 2004; 18: 326-8.
22. Wu J, Liu J, Waalkes MP, Cheng M, Li L, Li C, Yang Q,. High dietary fat exacerbates arsenic-induced liver fibrosis in mice. Exp Biol Med 2008; 233: 377-84. (Pubitemid 351328579)
23. Chen M, Chen J, Liao W, Zhu S, Yu J, Leung WK, Hu P, Sung JJ,. Immunization with attenuated Salmonella typhimurium producing catalase in protection against gastric Helicobacter pylori infection in mice. Helicobacter 2003; 8: 613-25. (Pubitemid 37553436)
24. Maffei CML, Mirels LF, Sobel RA, Clemons KV, Stevens DA,. Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis. Infect Immun 2004; 72: 2338-49. (Pubitemid 38419950)
25. Waibler Z, Kalinke U, Will J, Juan MHS, Pfeilschifter JM, Radeke HH,. TLR-ligand stimulated interleukin-23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells. Mol Immunol 2007; 44: 1483-9. (Pubitemid 44792752)
26. Davies G, Salter J, Hills M, Martin L, Sacks N, Dowsett M,. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clin Cancer Res 2003; 9: 2651-6. (Pubitemid 36842109)
27. Akira S, Sato S,. Toll-like receptors and their signaling mechanisms. Scand J Infect Dis 2003; 35: 555-62. (Pubitemid 37336872)
28. Bettelli E, Oukka M, Kuchroo VK,. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-50. (Pubitemid 46745409)
29. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, Khoury S, Oukka M, et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008; 9: 1347-55.
30. Risau W,. Differentiation of endothelium. FASEB J 1995; 9: 926-33.
31. Katiyar S, Elmets CA, Katiyar SK,. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem 2007; 18: 287-96. (Pubitemid 46590717)
32. Weiss DS, Raupach B, Takeda K, Akira S, Zychlinsky A,. Toll-like receptors are temporally involved in host defense. J Immunol 2004; 172: 4463-9. (Pubitemid 38375262)
33. Byrd-Leifer CA, Block EF, Takeda K, Akira S, Ding A,. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur J Immunol 2001; 31: 2448-57. (Pubitemid 32785364)
34. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM, Vogel SN,. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 2001; 166: 574-81. (Pubitemid 32038479)
35. Gondokaryono SP, Ushio H, Niyonsaba F, Hara M, Takenaka H, Jayawardana ST, Ikeda S, Okumura K, Ogawa H,. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol 2007; 82: 657-65. (Pubitemid 47367158)
36. Lasarte JJ, Casares N, Gorraiz M, Hervás-Stubbs S, Arribillaga L, Mansilla C, Durantez M, Llopiz D, Sarobe P, Borrás-Cuesta F, Prieto J, Leclerc C,. The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J Immunol 2007; 178: 748-56. (Pubitemid 46098855)
37. Yusuf N, Nasti TH, Huang CM, Huber BS, Jaleel T, Lin HY, Xu H, Elmets CA,. Heat shock proteins HSP27 and HSP70 are present in the skin and are important mediators of allergic contact hypersensitivity. J Immunol 2009; 182: 675-83.
38. Elmets CA, Zaidi SIA, Bickers DR, Mukhtar H,. Immunogenetic influences on the initiation stage of the cutaneous chemical carcinogenesis pathway. Cancer Res 1992; 52: 6106-9.
39. Watanabe T, Ohara J,. Functional nuclei of LPS-nonresponder C3H/HeJ mice after transfer into LPS-responder C3H/HeN cells by cell fusion. Nature 1981; 290: 58-9. (Pubitemid 11149142)
40. Bruns B, Maass D, Barber R, Horton J, Carlson D,. Alterations in the cardiac inflammatory response to burn trauma in mice lacking a functional Toll-like receptor 4 gene. Shock 2008; 30: 740-6.
41. Jordan JM, Woods ME, Olano J, Walker DH,. The absence of Toll-like receptor 4 signaling in C3H/HeJ mice predisposes them to overwhelming rickettsial infection and decreased protective Th1 responses. Infect Immun 2008; 76: 3717-24.
42. Nakamura H, Fukusaki Y, Yoshimura A, Shiraishi C, Kishimoto M, Kaneko T, Hara Y,. Lack of Toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H/HeJ mice in vivo. Oral Microbiol Immunol 2008; 23: 190-5. (Pubitemid 351519448)
43. Bauer AK, Dixon D, DeGraf, LM, Cho HY, Walker CR, Malkinson AM, Kleeberger SRJ,. Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis. J Natl Cancer Inst 2005; 97: 1778-81. (Pubitemid 41782287)
44. Ehrlich R, Efrati M, Bar-Eyal A, Wollberg M, Schiby G, Ran M, Witz IP,. Natural cellular reactivities mediated by splenocytes from mice bearing three types of primary tumor. Int J Cancer 1980; 26: 315-23. (Pubitemid 10049401)
45. Stevens RH, Cole DA, Rana RS, Graves JM,. Identification of carcinogens by measurement of cell mediated immunity, part 1. Immunity induced by rat pancreas and colon carcinogens. Environ Res 1980; 21: 143-9. (Pubitemid 10111214)
46. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, Hsu D, Xu R, Harpaz N, Dannenberg AJ, Subbaramaiah K, Cooper HS, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007; 133: 1869-81.
47. Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F, Hishinuma T, Goto J, Lotze MT, Kolls JK, Sasaki H,. IL-17 Enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005; 175: 6177-89. (Pubitemid 41508106)
48. Honorati MC, Neri S, Cattini L, Facchini A,. IL-17 enhances the susceptibility of U-2 OS osteosarcoma cells to NK cell lysis. Clin Exp Immunol 2003; 133: 344-49. (Pubitemid 37046957)
49. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT,. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003; 101: 2620-7. (Pubitemid 36857622)
50. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK,. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
51. Nam JS, Terabe M, Kang MJ, Chae H, Voong N, Yang YA, Laurence A, Michalowska A, Mamura M, Lonning S, Berzofsky JA, Wakefield LM,. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 2008; 68: 3915-23.
52. Yusuf N, Nasti TH, Katiyar SK, Jacobs MK, Seibert MD, Ginsburg AC, Timares L, Xu H, Elmets CA,. Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis. Cancer Res 2008; 68: 3924-30.
53. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM,. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160: 1212-18. (Pubitemid 28093417)